Complete Cytogenetic Response, Not Deep Molecular Response, Is Associated With Survival in Chronic Myeloid Leukemia Reply

被引：2
|
作者：
Hehlmann, Ruediger [1 ]
Hasford, Joerg [2 ]
Pfirrmann, Markus [2 ]
Lauseker, Michael [2 ]
Saussele, Susanne [1 ]
Hochhaus, Andreas [3 ]
机构：
[1] Heidelberg Univ, Univ Med Mannheim, Mannheim, Germany
[2] Univ Munich, Inst Med Informat Verarbeitung Biomet & Epidemiol, Munich, Germany
[3] Univ Klinkum Jena, Jena, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 27期
关键词：
KINASE INHIBITOR THERAPY; RECOMMENDATIONS; IMATINIB;
D O I：
10.1200/JCO.2014.56.3908
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3078 / +
页数：2
相关论文
共 50 条
  • [21] Delayed acute pancreatitis induced by nilotinib in a patient with chronic myeloid leukemia attaining sustained complete molecular response
    Wang, Shifang
    Desikan, Sai Prasad
    Jeffrey, Jay
    McClain III, Charles
    Desikan, Raman
    EJHAEM, 2020, 1 (01): : 309 - 311
  • [22] The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort
    Saugues, Sandrine
    Lambert, Celine
    Daguenet, Elisabeth
    Roth-Guepin, Gabrielle
    Huguet, Francoise
    Cony-Makhoul, Pascale
    Ansah, Hyacinthe Johnson
    Escoffre-Barbe, Martine
    Turhan, Ali
    Rousselot, Philippe
    Tchirkov, Andrei
    Hamroun, Dalil
    Hermet, Eric
    Pereira, Bruno
    Berger, Marc G.
    HAEMATOLOGICA, 2024, 109 (09) : 2893 - 2907
  • [23] Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib
    Ganguly, Sandip
    Lakshmaiah, K. C.
    Jacob, Linu Abraham
    Babu, Suresh
    Dasappa, Lokanatha
    Babu, K. S. Govind
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (01) : 82 - 86
  • [24] Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models
    Zad, Zahra
    Bonecker, Simone
    Wang, Taiyao
    Zalcberg, Ilana
    Stelzer, Gustavo T.
    Sabioni, Bruna
    Gutiyama, Luciana Mayumi
    Fleck, Julia L.
    Paschalidis, Ioannis Ch.
    LEUKEMIA RESEARCH, 2024, 141
  • [25] Is it time to reconsider molecular response milestones in chronic myeloid leukemia?
    Walia, Anushka
    Prasad, Vinay
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 562 - 563
  • [26] Factors Affecting Early Molecular Response in Chronic Myeloid Leukemia
    Chikkodi, Santosh V.
    Malhotra, Pankaj
    Naseem, Shano
    Khadwal, Alka
    Prakash, Gaurav
    Sahu, Kamal Kant
    Kumari, Savita
    Suri, Vikas
    Varma, Neelam
    Varma, Subhash
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S114 - S119
  • [27] Polycomb genes are associated with response to imatinib in chronic myeloid leukemia
    Crea, Francesco
    Di Paolo, Antonello
    Liu, Hui Hsuan
    Polillo, Marialuisa
    Clermont, Pier-Luc
    Guerrini, Francesca
    Ciabatti, Elena
    Ricci, Federica
    Barate, Claudia
    Fontanelli, Giulia
    Barsotti, Sara
    Morganti, Riccardo
    Danesi, Romano
    Wang, Yuzhuo
    Petrini, Mario
    Galimberti, Sara
    Helgason, Cheryl D.
    EPIGENOMICS, 2015, 7 (05) : 757 - 765
  • [28] Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients
    Iurlo, Alessandra
    Ubertis, Anna
    Artuso, Silvia
    Bucelli, Cristina
    Radice, Tommaso
    Zappa, Manuela
    Cattaneo, Daniele
    Mari, Daniela
    Cortelezzi, Agostino
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (01) : 63 - 66
  • [29] Deep molecular response in chronic myelogenous leukemia: ensuring accuracy and consistency
    Ip, H-W
    So, C-C
    LEUKEMIA, 2015, 29 (07) : 1620 - 1621
  • [30] Complete Molecular Response in Chronic Myeloid Leukemia After Six Months of Imatinib: A Single Center Experience
    Saleem, Umera
    Hafeez, Talha
    Raza, Syed Ali
    Tahir, Muhammad
    Khalid, Fatima
    Islam, Muhammad Khurrum
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
12345